| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 78.24B | 76.18B | 73.23B | 67.05B | 57.36B | 63.31B |
| Gross Profit | 35.88B | 31.39B | 29.92B | 27.02B | 21.74B | 27.80B |
| EBITDA | 6.71B | 5.29B | 6.70B | 6.65B | 3.25B | 4.24B |
| Net Income | 2.16B | 1.86B | 2.60B | 959.00M | -622.00M | 860.00M |
Balance Sheet | ||||||
| Total Assets | 96.26B | 97.49B | 93.27B | 91.00B | 85.77B | 87.91B |
| Cash, Cash Equivalents and Short-Term Investments | 29.54B | 29.12B | 26.98B | 21.49B | 20.02B | 16.14B |
| Total Debt | 3.43B | 289.00M | 490.00M | 314.00M | 556.00M | 4.06B |
| Total Liabilities | 19.05B | 20.82B | 20.06B | 19.82B | 16.71B | 18.20B |
| Stockholders Equity | 70.79B | 69.89B | 66.52B | 65.13B | 63.32B | 64.22B |
Cash Flow | ||||||
| Free Cash Flow | 2.10B | 3.39B | 5.36B | 2.87B | 5.95B | -2.01B |
| Operating Cash Flow | 3.55B | 4.92B | 6.81B | 4.07B | 7.69B | 6.21B |
| Investing Cash Flow | -2.78B | -2.08B | -887.00M | -1.26B | -185.00M | -5.68B |
| Financing Cash Flow | -1.17B | -2.20B | -2.11B | -2.07B | -5.38B | 1.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥433.02B | 16.53 | 9.09% | 1.73% | 2.18% | 60.81% | |
70 Outperform | ¥2.72T | 24.05 | 11.50% | 2.41% | 4.62% | 47.68% | |
69 Neutral | ¥331.52B | 19.79 | 2.72% | 2.61% | 1.37% | -5.60% | |
69 Neutral | ¥287.38B | 30.42 | 5.84% | 3.92% | -1.16% | 36.30% | |
63 Neutral | ¥138.78B | 62.64 | 3.10% | 1.45% | 3.95% | -25.42% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | ¥1.17T | -22.37 | ― | 2.11% | -1.20% | -2896.72% |